Latest News for Hoth Therapeutics Stock (NASDAQ:HOTH)

Tuesday, December 05, 2023

Market-Moving News for December 5th
Benzinga Newsdesk - 3 days ago
Hoth Therapeutics Announces It Has Successfully Completed Manufacturing Of Its Cancer Fighting HT-KIT For IND-Enabling Studies
Benzinga Newsdesk - 3 days ago

Tuesday, November 14, 2023

Hoth Therapeutics Announces Completion Of Pre-IND Meeting With FDA Regarding Development Of Hoth's Cancer Fighting HT-KIT; Hoth Intends To Continue Development Under Orphan Drug Designation
Benzinga Newsdesk - Nov 14, 2023, 8:38AM

Thursday, October 05, 2023

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Oct 5, 2023, 1:22PM
Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative For Drug Discovery; The New Wholly Owned Subsidiary Will Screen For Rare Disease Therapeutics
Benzinga Newsdesk - Oct 5, 2023, 10:06AM
Hoth Therapeutics On Oct. 4, Filed Articles Of Incorporation With State Of Nevada For Formation Of New Wholly-Owned Subsidiary, Merveille.ai
Benzinga Newsdesk - Oct 5, 2023, 8:18AM

Monday, October 02, 2023

Stocks That Hit 52-Week Lows On Monday
Benzinga Insights - Oct 2, 2023, 1:00PM

Thursday, September 14, 2023

EF Hutton Maintains Buy Rating for Hoth Therapeutics: Here's What You Need To Know
Benzinga Insights - Sep 14, 2023, 1:00PM
EF Hutton Maintains Buy on Hoth Therapeutics, Lowers Price Target to $7.5
Benzinga Newsdesk - Sep 14, 2023, 12:17PM

Wednesday, September 13, 2023

Hoth Therapeutics' Investigational Cancer Drug Shows Encouraging Preclinical Activity In Stomach Cancers
Vandana Singh - Sep 13, 2023, 1:50PM
Hoth Therapeutics Announces $2.89M Registered Direct Offering Of 1.1M Shares Of Stock Priced At-The-Market Under Nasdaq Rules
Benzinga Newsdesk - Sep 13, 2023, 1:46PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Sep 13, 2023, 9:06AM
Hoth Therapeutics shares are trading higher after the company announced HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis killed cancer cells in both gastrointestinal stromal tumors and acute myeloid leukemina.
Benzinga Newsdesk - Sep 13, 2023, 8:28AM
Hoth Therapeutics Says HT-KIT, A New Molecular Entity, For Advance Systemic Mastocytosis Shows Cancer Cells Killing In Both Gastrointestinal Stromal Tumors And Acute Myeloid Leukemia In Preclinical Study
Benzinga Newsdesk - Sep 13, 2023, 8:20AM

Tuesday, September 12, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Sep 12, 2023, 5:31PM

Monday, September 11, 2023

Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug Submission For HT-KIT, Treatment For Cancer Patients
Benzinga Newsdesk - Sep 11, 2023, 10:06AM

Wednesday, September 06, 2023

Hoth Therapeutics Has Completed Its Analysis Of The Data From Its Phase 1B Clinical Trial Of Biolexa As A Therapeutic For Atopic Dermatitis; 78% Of Patients Reported That Their Overall Health Had Improved Since Starting Biolexa
Benzinga Newsdesk - Sep 6, 2023, 8:13AM

Wednesday, August 23, 2023

EF Hutton Assumes Hoth Therapeutics at Buy, Announces Price Target of $14
Benzinga Newsdesk - Aug 23, 2023, 4:35AM

Wednesday, August 09, 2023

Hoth Therapeutics Alzheimer's Treatment Shows Improvement In Cognitive Function, Anxiety
Vandana Singh - Aug 9, 2023, 9:32AM
Hoth Therapeutics Announces Preclinical End Point Results Of HT-ALZ Treatment For Alzheimer's Disease
Benzinga Newsdesk - Aug 9, 2023, 8:16AM

Tuesday, July 25, 2023

Hoth Therapeutics Announces Major Milestone Of First Patient Dosed In Phase 2a Clinical Trial
Happy Mohamed - Jul 25, 2023, 8:12AM

Wednesday, July 19, 2023

Hoth Therapeutics Receives Protocol Approval For HT-001 Cancer Therapeutic; FDA Approved Trial Now Has Two Sites Approved With Additional Sites In Approval Process
Happy Mohamed - Jul 19, 2023, 8:05AM

Friday, July 07, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Jul 7, 2023, 9:12AM

Thursday, June 22, 2023

California, Minnesota, Wisconsin Join FTC Suit To Stop Amgen $27.8B Deal To Buy Horizon Therapeutics -
Benzinga Newsdesk - Jun 22, 2023, 4:45PM

Tuesday, June 20, 2023

Analyst Expectations for Hoth Therapeutics's Future
Benzinga Insights - Jun 20, 2023, 2:01PM
Benchmark Reiterates Speculative Buy on Hoth Therapeutics, Maintains $5 Price Target
Benzinga Newsdesk - Jun 20, 2023, 8:17AM

Wednesday, June 14, 2023

Hoth Therapeutics shares are trading higher after the company received IRB approval to proceed with its first-in-human phase 2a trial of HT-001 for skin toxicities associated with epidermal growth factor receptor inhibitors
Benzinga Newsdesk - Jun 14, 2023, 8:18AM
Hoth Therapeutics Announces IRB Approval For FDA Cleared First-In-Human Clinical Trial Of HT-001 At Second Clinical Site
Benzinga Newsdesk - Jun 14, 2023, 8:13AM

Wednesday, June 07, 2023

Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Jun 7, 2023, 2:02PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Jun 7, 2023, 9:06AM
Why Yext Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jun 7, 2023, 8:07AM
Fear & Greed Index Moves To 'Extreme Greed' Zone After US Stocks Settle Higher
Lisa Levin - Jun 7, 2023, 3:47AM

Tuesday, June 06, 2023

Dow Falls Over 100 Points; Hoth Therapeutics Shares Spike Higher
Lisa Levin - Jun 6, 2023, 2:40PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jun 6, 2023, 1:31PM
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jun 6, 2023, 1:04PM
Hoth Therapeutics Stock Almost Doubles in Tuesday's Trading Session, Here's Why
Vandana Singh - Jun 6, 2023, 1:01PM
Nasdaq Edges Higher; Joann Shares Plummet
Lisa Levin - Jun 6, 2023, 12:01PM
Hoth Therapeutics shares are trading higher after the company announced preclinical results for HT-ALZ for the treatment of Alzheimer's disease.
Benzinga Newsdesk - Jun 6, 2023, 11:18AM
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, June 6, 2023: AAPL, DIS, COIN, GME, HOTH
Benzinga Newsdesk - Jun 6, 2023, 9:08AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jun 6, 2023, 9:06AM
High-Impact Movers for June 6th
Benzinga Newsdesk - Jun 6, 2023, 8:37AM
Hoth Therapeutics Announces Preclinical Results For HT-ALZ In Alsheimer's Disease, Showing 'Positive Effects on Cognitive Function'
Benzinga Newsdesk - Jun 6, 2023, 8:04AM

Thursday, June 01, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 1, 2023, 9:07AM
Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jun 1, 2023, 7:55AM
EF Hutton Assumes Hoth Therapeutics at Buy, Announces Price Target of $14
Benzinga Newsdesk - Jun 1, 2023, 4:47AM

Wednesday, May 31, 2023

CORRECTION: EF Hutton Assumed Buy And $14 PT On Hoth
Benzinga Newsdesk - May 31, 2023, 5:32PM
EF Hutton Assumes Buy And $14 PT On Hoth
Bill Haddad - May 31, 2023, 5:01PM

Friday, May 12, 2023

Hoth Therapeutics Shares Resume Trade
Happy Mohamed - May 12, 2023, 9:10AM
Hoth Therapeutics, Inc. Shares To Resume Trade At 9:10 a.m. ET
Happy Mohamed - May 12, 2023, 8:43AM
Hoth Therapeutics And Algorithm Sciences Terminate Letter Of Intent To Merge
Happy Mohamed - May 12, 2023, 8:39AM

Open1.300	Close1.270
Vol / Avg.40.990K / 246.004K	Mkt Cap5.563M
Day Range1.220 - 1.350	52 Wk Range0.990 - 12.500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Hoth Therapeutics Stock (NASDAQ:HOTH)

Tuesday, December 05, 2023

Tuesday, November 14, 2023

Thursday, October 05, 2023

Monday, October 02, 2023

Thursday, September 14, 2023

Wednesday, September 13, 2023

Tuesday, September 12, 2023

Monday, September 11, 2023

Wednesday, September 06, 2023

Wednesday, August 23, 2023

Wednesday, August 09, 2023

Tuesday, July 25, 2023

Wednesday, July 19, 2023

Friday, July 07, 2023

Thursday, June 22, 2023

Tuesday, June 20, 2023

Wednesday, June 14, 2023

Wednesday, June 07, 2023

Tuesday, June 06, 2023

Thursday, June 01, 2023

Wednesday, May 31, 2023

Friday, May 12, 2023